Cargando…

Monotherapy versus Combination Therapy against Nonbacteremic Carbapenem-resistant Gram-negative Infections: A Retrospective Observational Study

BACKGROUND: Superiority of colistin–carbapenem combination therapy (CCCT) over colistin monotherapy (CMT) against carbapenem-resistant Gram-negative bacterial (CRGNB) infections is not conclusively proven. AIM: The aim of the current study was to analyze the effectiveness of both strategies against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghafur, Abdul, Devarajan, Vidyalakshmi, Raja, T., Easow, Jose, Raja, M. A., Sreenivas, Sankar, Ramakrishnan, Balasubramaniam, Raman, S. G., Devaprasad, Dedeepiya, Venkatachalam, Balaji, Nimmagadda, Ramesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752790/ https://www.ncbi.nlm.nih.gov/pubmed/29307962 http://dx.doi.org/10.4103/ijccm.IJCCM_243_17

Ejemplares similares

Colistin Nephrotoxicity in Adults: Single Centre Large Series from India
por: Ghafur, Abdul, et al.
Publicado: (2017)

Retrospective Study of Nephrotoxicity Rate among Adult Patients Receiving Colistin Compared to β-lactam Antibiotics
por: Ghafur, Abdul, et al.
Publicado: (2019)

Elizabethkingia meningoseptica bacteremia in immunocompromised hosts: The first case series from India
por: Ghafur, Abdul, et al.
Publicado: (2013)

Antibiotic costs in bacteremic and nonbacteremic patients treated with the de-escalation approach
por: Evodia, E, et al.
Publicado: (2008)

Feasibility and Safety of Peripheral Intravenous Administration of Vasopressor Agents in Resource-limited Settings
por: Padmanaban, Ajay, et al.
Publicado: (2020)

Salmonella enterica Serotype Choleraesuis Infection of the Knee and Femur in a Nonbacteremic Diabetic Patient
por: Sy, Alexander M., et al.
Publicado: (2013)

2717. The Impact of Pneumococcal Conjugate Vaccine in Nonbacteremic Pneumococcal Pneumonia Among Cancer Patients
por: Lee, Yeon Joo, et al.
Publicado: (2019)

Epidemiology and Outcomes of HIN1 Pneumonia in ICU
por: Golagana, Vinya, et al.
Publicado: (2023)

A Case of Severe Aeromonas Bacteremia with Necrotizing Fasciitis of Lower Limb and Fournier ' s Gangrene in a Post-Allogenic Unrelated Hematopoietic Stem Cell Transplant Recipient
por: Das, Bikram, et al.
Publicado: (2022)

P262: Successful implementation of an infection control programme in a tertiary care oncology centre from a developing country
por: Ghafur, A, et al.
Publicado: (2013)

Acute encephalitis syndrome following scrub typhus infection
por: Kar, Ayan, et al.
Publicado: (2014)

Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli
por: Hao, Min, et al.
Publicado: (2022)

Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials
por: Cheng, I-Ling, et al.
Publicado: (2018)

Dissemination of carbapenem resistance and plasmids encoding carbapenemases in Gram-negative bacteria isolated in India
por: Manohar, Prasanth, et al.
Publicado: (2021)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19
por: Ikewaki, Nobunao, et al.
Publicado: (2021)

Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
por: Lerner, Jason T, et al.
Publicado: (2010)

Clinical, Epidemiological, and Microbiological Profile of Patients with Vancomycin-Resistant Enterococci from a Tertiary Care Hospital
por: Vidyalakshmi, PR, et al.
Publicado: (2012)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria
por: Lu, Jiayue, et al.
Publicado: (2022)

P297: Increasing needle stick injuries amongst the radiology team-needs attention!
por: Ghafur, A, et al.
Publicado: (2013)

Too many too soon - fever following PET CT
por: Ghafur, A, et al.
Publicado: (2015)

Possible Ambiguity in Interpretation Between Immunoglobulin G4-Related Disease (IgG4-RD) and Sarcoidosis in a Post-COVID-19 Pandemic
por: Gurunathan, Rajesh, et al.
Publicado: (2023)

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
por: Nordmann, Patrice, et al.
Publicado: (2019)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

“Save Antibiotics, Save lives”: an Indian success story of infection control through persuasive diplomacy
por: Ghafur, A, et al.
Publicado: (2012)

The role of carbapenems in initial therapy for serious Gram-negative infections
por: Rahal, James J
Publicado: (2008)

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
por: Ramphal, Reuben
Publicado: (2008)

Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014)

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
por: Doi, Yohei
Publicado: (2019)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022)

Potential Effects of Nichi Glucan as a Food Supplement for Diabetes Mellitus and Hyperlipidemia: Preliminary Findings from the Study on Three Patients from India
por: Dedeepiya, Vidyasagar Devaprasad, et al.
Publicado: (2012)

Tumor Attributes Predicting Cutaneous Metastatic Destiny: A Report of Two Interesting Cases
por: Gurumurthi, Ravichandran, et al.
Publicado: (2014)

Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
por: El Hafi, Bassam, et al.
Publicado: (2019)

Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods
por: Richter, Stefan E, et al.
Publicado: (2019)

Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria
por: Garg, Atul, et al.
Publicado: (2019)

Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections
por: Tabak, Ying P., et al.
Publicado: (2020)

The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
por: Chopra, Teena
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k96313qqoq5s3tsqjfj57a7e1a